Timeline for Applications
All applications will be reviewed by the K12 Paul Calabresi Clinical & Translational Oncology Training Program
Advisory Council Recruitment Subcommittee. The following review criteria will be taken into consideration:
♦ Evidence of a commitment to a career in patient-oriented cancer research (i.e., prior training, specialized skills,
prior research accomplishments, etc.).
♦ Potential to develop into a successful researcher and leader of multidisciplinary research teams (e.g., letters of
recommendation (candidates already in MUSC junior faculty positions must include a letter from departmental
chair explicitly committing their support and guaranteed protected time), prior research accomplishments and
experiences, leadership roles during undergraduate, graduate and clinical training, etc.).
♦ Prior research productivity (i.e., papers, abstracts, etc.).
♦ Performance record during clinical training (i.e., Letter(s) of
recommendation from the Program Director(s) of
the candidates’ advanced clinical specialty or subspecialty
outlining their training, teaching and/or awards, etc.).
For those candidates with a PhD, letters from their thesis
mentor and postdoctoral mentors will be required.
♦ Academic record during graduate training.
♦ Compatibility with the Program’s areas of concentration
Items Needed for a Complete Application
Note: Only PDFs can be uploaded in the application.
|Current Curriculum Vitae|
|Completed application form|
(click here for application form)
|Research Plan (click here for description)|
|Up to 5 Letters of Reference: All applicants must include letters of support from their mentors (1 Primary and 2 Secondary): Primary Mentors must state their commitment to meet with the Scholar one-on-one on a weekly basis; Secondary Mentors must state their commitment to meet with the Scholar's mentor team on a monthly basis. Applicants must also include a letter of support from their MUSC Department Chair or Division Chief guaranteeing the 75% dedicated full-time professional effort (50% for surgeon applicants) to the K12 Paul Calabresi Career Development for Clinical & Translational Oncology Program. Additionally, applicants may include one other letter of support describing their potential for patient-oriented research.|